Evidence map›Paper›PMID 37071401›Full record

SynthesisVector borne and zoonotic diseases (Larchmont, N.Y.)2023

Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005-2020).

Leah Burn, Andreas Pilz, Andrew Vyse, Aura Victoria Gutiérrez Rabá, Frederick J Angulo, Thao Mai Phuong Tran, Mark A Fletcher, Bradford D Gessner, Jennifer C Moïsi, James H Stark

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevalence and Risk Factors ofPathogens (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Repeated cross-sectional surveys show a decreasing trend inEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  6. Seroprevalence ofPathogens (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Serological Assessment ofPathogens (Basel, Switzerland) · 2024
    Article
  11. Tick-Borne Bacterial Diseases in Europe: Threats to public health.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Review
  12. Prevalence of Lyme Disease and Relapsing FeverPathogens (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 6 countries.

Leah BurnP95 Pharmacovigilance & Epidemiology, Princeton, New Jersey, USA.
Andreas PilzPfizer Global Medical Affairs, Vaccines, Vienna, Austria.
Andrew VysePfizer Vaccines Medical, Walton Oaks, United Kingdom.
Aura Victoria Gutiérrez RabáP95 Pharmacovigilance & Epidemiology, Leuven, Belgium.
Frederick J AnguloPfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
Thao Mai Phuong TranP95 Pharmacovigilance & Epidemiology, Leuven, Belgium.
Mark A FletcherPfizer Emerging Markets Medical Affairs, Vaccines, Paris, France.
Bradford D GessnerPfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
Jennifer C MoïsiPfizer Medical Development, Scientific and Clinical Affairs, Vaccines, Paris, France.
James H StarkPfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
Pfizer (United States) · USNetherlands Pharmacovigilance Centre Lareb · NLPfizer (France) · FRPfizer (Austria) · ATPfizer (United Kingdom) · GBPrinceton Theological Seminary · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Borrelia burgdorferiBorrelia burgdorferi GroupLyme DiseaseTicksAnimalsEuropeSeroepidemiologic StudiesdiagnosticsepidemiologyEuropeLyme borreliosisseropositivityseroprevalence

Identifiers

PMID37071401
PMCPMC10122246
OpenAlexW4366240405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.